ethanolamine has been researched along with Allergic Encephalomyelitis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Balimane, P; Barrish, JC; Borowski, V; Carter, PH; Cornelius, G; Cvijic, ME; D'Arienzo, C; Dyckman, AJ; Galella, MA; Gillooly, K; Gilmore, JL; Haque, L; Levesque, PC; Li, JP; Marino, A; McIntyre, KW; Mukhopadhyay, P; Pitts, WJ; Salter-Cid, L; Shen, DR; Sheppeck, JE; Taylor, T; Tebben, AJ; Warrack, B; Watterson, SH; Xie, J; Yarde, M | 1 |
1 other study(ies) available for ethanolamine and Allergic Encephalomyelitis
Article | Year |
---|---|
Discovery and Structure-Activity Relationship (SAR) of a Series of Ethanolamine-Based Direct-Acting Agonists of Sphingosine-1-phosphate (S1P1).
Topics: Animals; Arthritis; Dogs; Encephalomyelitis, Autoimmune, Experimental; Ethanolamine; Female; Haplorhini; Humans; Lymphocyte Count; Lymphocytes; Male; Mice; Mice, Inbred C57BL; Rats; Rats, Inbred Lew; Receptors, Lysosphingolipid; Structure-Activity Relationship | 2016 |